According to a recent study, the R248Q p53 mutation is associated with hyperactive STAT3/JAK signaling, and therapeutic ablation of this gain-of-function mutant p53 in colorectal cancer inhibits STAT3-mediated tumor growth and invasion [100]. Here, TP53 is linked to colorectal cancer.